Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

1(14%)

Results Posted

33%(2 trials)

Phase Distribution

Ph phase_1

43%

Ph not_applicable

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

3(50.0%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Detailed Status

Completed6

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (50.0%)

N/A3 (50.0%)

Trials by Status

recruiting114%

completed686%

Recent Activity

1 active trials

Showing 5 of 7

completed

Clinical Trials (7)

Showing 7 of 7 trials

NCT07126938

Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device

Completed

NCT06158880Not Applicable

Alcohol & Men's Sexual Risk Behaviors

Recruiting

NCT03900650Not Applicable

Men's Sexual Risk Behaviors: Alcohol, Sexual Aggression, and Emotional Factors

Completed

NCT03165942Phase 1

Neuroendocrine Response to Oral Alcohol Administration

Completed

NCT00816231Not Applicable

Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

Completed

NCT01380691Phase 1

A Study of LY2216684 in Healthy Participants

Completed

NCT01638364Phase 1

Dopamine Release in the Human Brain Following Alcohol Administration

Completed

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7